Global WholeHealth Partners Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GWHP research report →
About the company
Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests. These diagnostic tools are designed for wide accessibility, catering to both over-the-counter consumer purchases and professional point-of-care settings such as hospitals, physicians' offices, and various medical clinics.
- CEO
- Edgar B. Gonzalez
- IPO
- 2015
- HQ
- San Clemente, CA, US
Price Chart
- Market Cap
- $1.31K
- P/E
- -0.00
- P/S
- 0.18
- P/B
- -0.00
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
- Gross Margin
- -1518.64%
- Op Margin
- -56759.32%
- Net Margin
- -69898.31%
- ROE
- 618.63%
- ROIC
- 477.11%
- Revenue
- $7.38K · -81.65%
- Net Income
- $-5,155,000 · 42.94%
- EPS
- $-0.05 · 60.79%
- Op Income
- $-4,186,000
- FCF YoY
- -204.53%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -11.47
- Avg Volume
- 6
Get TickerSpark's AI analysis on GWHP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GWHP coverage
Recent articles, reports, and earnings notes.
No research on GWHP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GWHP report →Similar companies
Peers in the same neighborhood.